Pharma Journalist -

Johnson & Johnson (the Company) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine,…
Read More...

Welldoc, Inc., and Eli Lilly and Company announced a collaboration and licensing agreement to integrate Welldoc's software into Lilly's connected insulin solutions, currently in…
Read More...

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to…
Read More...

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, announced a collaboration with the Mayo Clinic to advance research in…
Read More...

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and UCLA…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and LYSA-LYSARC-CALYM announced that they have entered a strategic research collaboration to study valemetostat (DS-3201),…
Read More...

Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. in the development of a data management and collaboration solution for the…
Read More...

Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early phase clinical trials. Vibegron is a beta-3 adrenergic receptor (β3)…
Read More...

Crown Bioscience (CrownBio), JSR Life Sciences and Cambridge Quantum Computing (CQC) today announced a partnership agreement to explore the application of quantum technology to drive…
Read More...

QIAGEN and INOVIO Pharmaceuticals announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products…
Read More...